Recombinant human bone morphogenetic protein 2 in augmentation procedures: case reports.

Area of Science:

• Oral surgery
• Regenerative medicine
• Dental implantology

Background:

• Successful endosseous implant rehabilitation requires adequate bone volume.
• Traditional autogenous bone grafts have limitations including availability and patient morbidity.
• Alternative bone augmentation strategies are needed for edentulous patients.

Observation:

• Recombinant human bone morphogenetic protein 2 (rhBMP-2) facilitates bone regeneration in the oral environment.
• rhBMP-2 was utilized in maxillary sinus elevation and alveolar augmentation procedures.
• These procedures aimed to enable dental implant placement in patients with insufficient bone volume.

Findings:

• The application of rhBMP-2 in maxillary sinus elevation procedures was demonstrated.
• rhBMP-2 facilitated augmentation procedures in the maxilla.
• Clinical benefits were observed with the use of rhBMP-2 in alveolar augmentation.

Implications:

• rhBMP-2 presents a viable alternative to autogenous bone grafts for dental implant site preparation.
• This regenerative approach can improve outcomes for edentulous patients seeking dental implants.
• Further research into rhBMP-2 applications may expand regenerative options in oral surgery.